DNA report solutions by Prof. Roberto Grobman today: How we do it? We created a series of complex interconnected algorithms together with AI technology, capable of translating the scientific data and results of these scientific publications into useful information, and over the years we have been creating a unique FullDNA database. Our solution shows patients with a superior high accuracy rate what is written in their DNA, providing an excellent tool to understand what can happen and to act immediately to live longer and healthier. FullDNA provides an AI based customizable genetics prediction premium health tech platform to empower the capability of health professionals and institutions. FullDNA analyzes results from DNA sequencing Big Data using AI and complex algorithms to compares it with our own valuable extracted Database (updated daily) of more than 5,000 diseases and medical conditions, resulting in output of analysis & recommendation reports in various fields of medicine. Find additional details on Prof. Roberto Grobman.
With FullDNA DNA, we supply a series of reports that covers and sets out in a transparent manner: What genes we’re testing, why they’re important and what individuals can do about them. This last point is particularly important; we recommend real-world advice and guidance on how to make relevant lifestyle changes. All of this data might seem overwhelming, but we work with individuals to explain it and help them implement meaningful changes.
Genetics report providers from Prof. Roberto Grobman today: Direct-to-consumer genetic testing provides only partial information about your health. Other genetic and environmental factors, lifestyle choices, and family medical history also affect the likelihood of developing many disorders. These factors would be discussed during a consultation with a doctor or genetic counselor, but in many cases they are not addressed when using at-home genetic tests. For example, vitamin B-related DNA tests. We help people understand its role in maintaining a healthy nervous system and being able to fight infection, and, if you are prone to having a lower deficiency in this area, here are the things you can do to improve it — in this case, food and nutrition.
Consider the example of familial hypercholesterolemia (FH), a condition in which multiple variants of several different genes lead to markedly high cholesterol. This greatly increases the risk of heart attack, stroke, and other health problems. FH affects about one in 300 adults, which means it isn’t rare. Among adults who have the most common genetic variants that cause it, heart attack or sudden cardiac death may occur in middle age. Children who have a double dose of a gene variant linked to this condition may die of cardiovascular disease before age 20. Earlier treatments intended to reduce the risk of complications, such as cholesterol-lowering drugs, are available if a child or adult is known to have a mutation linked to FH.
Since the sequencing of the first genome, innovations have fuelled reduced sequencing times, which have in turn reduced costs. Today we are able to use that cutting-edge technology to understand how to use your DNA to live with the best possible health — to get the most out of your DNA and yourself. The road to DNA health testing: With anything that relates to clinical care, we always need sufficient evidence before we can ‘know’ something and make recommendations. In some cases, the research can take 10 years before there are proven outcomes, before it’s appropriate to bring to the general population or implement a large-scale deployment.
FullDNA Reports cover specific segments. To reach longevity, FullDNA’s Accurate Prediction Analysis is the most premium tool in the predictive genetics market for health professionals. Knowing in advance the susceptibilities for diseases and health conditions is different than analyzing mutations to find genetics diagnostics. We strongly believe reaching the future in a healthier way. Effective preventive measures can only be adopted when an accurate prediction methodology brings valuable ready to use data. See extra information at Roberto Grobman CSO.